Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
BMC Health Services Research
|
April 28, 2022
Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy
Nicola Ferrante, Daniela Ritrovato, Rossella Bitonti, et al.
Plos One
|
March 14, 2019
Economic value of narrow-band imaging versus white light endoscopy for the diagnosis and surveillance of Barrett's esophagus: Cost-consequence model
Gianluca Furneri, Romy Klausnitzer, Laura Haycock, et al.
BMC Health Services Research
|
June 30, 2019
Cost-effectiveness analysis of escalating to natalizumab or switching among immunomodulators in relapsing-remitting multiple sclerosis in Italy
Gianluca Furneri, Laura Santoni, Chiara Ricella, et al.
BMC Health Services Research
|
January 15, 2023
Cost-effectiveness analysis of gemtuzumab ozogamicin for the treatment of de novo CD33-positive Acute Myeloid Leukaemia (AML) in Italy
Roberto Cairoli, Gianluca Furneri, Roberto Di Virgilio, et al.
Current Opinion in Pulmonary Medicine
|
January 3, 2012
The economic burden of chronic obstructive pulmonary disease in the elderly: results from a systematic review of the literature
Silvia Bustacchini, Carlos Chiatti, Gianluca Furneri, et al.
Aging Clinical and Experimental Research
|
February 20, 2008
Sertraline treatment for depression associated with acute coronary syndromes: a cost analysis from the viewpoint of the Italian Healthcare System
Fabrizia Lattanzio, Antonio Cherubini, Gianluca Furneri, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
September 11, 2020
Using 2nd generation basal insulins in type 2 diabetes: Costs and savings in a comparative economic analysis in Italy, based on the BRIGHT study
Raffaele Napoli, Francesca Fanelli, Luca Gazzi, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
September 28, 2020
Minimally Invasive Surgery in Mild-to-Moderate Glaucoma Patients in Italy: Is It Time to Change?
Ciro Costagliola, Mario Sbordone, Stefano Gandolfi, et al.
BMC Health Services Research
|
August 17, 2021
Cost-utility analysis of trabecular micro-bypass stents (TBS) in patients with mild-to-moderate open-angle Glaucoma in Italy
Antonio Maria Fea, Francesco Cattel, Stefano Gandolfi, et al.
Global & Regional Health Technology Assessment
|
January 11, 2023
Antonio Costanzo, Gianluca Furneri, Rossella Bitonti, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
BMC Health Services Research
|
April 28, 2022
Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy
Nicola Ferrante, Daniela Ritrovato, Rossella Bitonti, et al.
Plos One
|
March 14, 2019
Economic value of narrow-band imaging versus white light endoscopy for the diagnosis and surveillance of Barrett's esophagus: Cost-consequence model
Gianluca Furneri, Romy Klausnitzer, Laura Haycock, et al.
BMC Health Services Research
|
June 30, 2019
Cost-effectiveness analysis of escalating to natalizumab or switching among immunomodulators in relapsing-remitting multiple sclerosis in Italy
Gianluca Furneri, Laura Santoni, Chiara Ricella, et al.
BMC Health Services Research
|
January 15, 2023
Cost-effectiveness analysis of gemtuzumab ozogamicin for the treatment of de novo CD33-positive Acute Myeloid Leukaemia (AML) in Italy
Roberto Cairoli, Gianluca Furneri, Roberto Di Virgilio, et al.
Current Opinion in Pulmonary Medicine
|
January 3, 2012
The economic burden of chronic obstructive pulmonary disease in the elderly: results from a systematic review of the literature
Silvia Bustacchini, Carlos Chiatti, Gianluca Furneri, et al.
Aging Clinical and Experimental Research
|
February 20, 2008
Sertraline treatment for depression associated with acute coronary syndromes: a cost analysis from the viewpoint of the Italian Healthcare System
Fabrizia Lattanzio, Antonio Cherubini, Gianluca Furneri, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
September 11, 2020
Using 2nd generation basal insulins in type 2 diabetes: Costs and savings in a comparative economic analysis in Italy, based on the BRIGHT study
Raffaele Napoli, Francesca Fanelli, Luca Gazzi, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
September 28, 2020
Minimally Invasive Surgery in Mild-to-Moderate Glaucoma Patients in Italy: Is It Time to Change?
Ciro Costagliola, Mario Sbordone, Stefano Gandolfi, et al.
BMC Health Services Research
|
August 17, 2021
Cost-utility analysis of trabecular micro-bypass stents (TBS) in patients with mild-to-moderate open-angle Glaucoma in Italy
Antonio Maria Fea, Francesco Cattel, Stefano Gandolfi, et al.
Global & Regional Health Technology Assessment
|
January 11, 2023
Antonio Costanzo, Gianluca Furneri, Rossella Bitonti, et al.
Page
of 3